Aquestive Therapeutics, Inc. (AQST)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

1.7300

+0.3400

(+24.46%)

At close: 04:00PM EDT

1.8600

+0.13

(+7.51%)

After hours:

07:59PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

GlobeNewswire
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space
Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames Kenneth Truitt, M.D., with over 25 years of clinical and regulatory experience across biotechnology and large pharmaceutical companies, as Chief Medical Officer Reports inducement grant to Dr. Truitt under Nasdaq Listing Rule 5635(c)(4) WARREN, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (Nasdaq: AQST), a pharmaceutica
Zacks
Pacira's (PCRX) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
Pacira's (PCRX) earnings and revenues fall shy of estimates in the second quarter of 2022.
Simply Wall St.
A number of insiders bought Aquestive Therapeutics, Inc. (NASDAQ:AQST) stock last year, which is great news for shareholders
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Advertisement